Hos patienter med varianten, udviste 4/ 26 (15%) patienter forbedring i nekroinflammatorisk score og 8/ 26 (31%) patienter udviste forværring sammenlignet med præ- behandling.
In patients with the variant, 4/ 26 (15%) patients showed improvement in necroinflammatory score and 8/ 26 (31%) patients worsened compared to pre-treatment.